Don't Just Read the News, Understand It.

Published 3 days ago • loading... • Updated 3 days ago

Innovent Announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China Were Orally Presented at ADA 85th Scientific Sessions

Summary by PR Newswire

/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

11 Articles

11 Articles

All

Left

1

Center

5

Right

1

Gilbert Sun News

+9 Reposted by 9 other sources

Innovent announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China were Orally Presented at ADA 85th Scientific Sessions

SAN FRANCISCO and SUZHOU, China, June 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major…

3 days ago

Read Full Article

Innovent announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China were Orally Presented ...

SAN FRANCISCO and SUZHOU, China, June 24, 2025

3 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources11

Leaning Left1Leaning Right1Center5Last Updated2 days agoBias Distribution

71% Center

Bias Distribution

71% of the sources are Center

71% Center

Untracked bias

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

World News broke the news in United States 3 days ago on Tuesday, June 24, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.